CoChat

Opportunities and Challenges for the Nasal Administration of Nanoemulsions

Comfort, Claurice, Garrastazu, Gabriela, Pozzoli, Michele, Sonvico, Fabio · 2015 · Current Topics in Medicinal Chemistry

The DOI matches its Crossref record; 81 of the 81 references it cites were found in a registry or an index.

Abstract

Nasal delivery has become a growing area of interest for drug administration as a consequence of several practical advantages, such as ease of administration and non-invasiveness. Moreover, the avoidance of hepatic first-pass metabolism and rapid and efficient absorption across the permeable nasal mucosa offer a promising alternative to other traditional administration routes, such as oral or parenteral delivery. In fact, nasal delivery has been proposed for a number of applications, including local, systemic, direct nose-to-brain and mucosal vaccine delivery. Nanoemulsions, due to their stability, small droplet size and optimal solubilization properties, represent a versatile formulation approach suitable for several administration routes. Nanoemulsions demonstrated great potential in nasal drug delivery, increasing the absorption and the bioavailability of many drugs for systemic and nose-to-brain delivery. Furthermore, they act as an active component, i.e. an adjuvant, in nasal mucosal vaccinations, displaying the ability to induce robust mucosal immunity, high serum antibodies titres and a cellular immune response avoiding inflammatory response. Interestingly, nanoemulsions have not been proposed for the treatment of local ailments of the nose. Despite the promising results in vitro and in vitro, the application of nanoemulsions for nasal delivery in humans appears mainly hindered by the lack of detailed toxicology studies to determine the effect of these formulations on the nasal mucosa and cilia and the lack of extensive clinical trials.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.2174/1568026615666150108144655

Cites

81 of 81 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 81 references

Research works printed but not linked: 21

  1. [3][3] Sarkar, M. A. Drug metabolism in the nasal mucosa. Pharm. Res., 1992 , 9 (1), 1-9. -
  2. [4][4] Pardeshi, C. V.; Belgamwar, V. S. Direct nose to brain drug delivery via integrated nerve pathways bypassing the blood-brain barrier: an excellent platform for brain targeting. Expert Opin. Drug Deliv., 2013 , 10 (7), 957-972. -
  3. [10][10] Grassin-Delyle, S.; Buenestado, A.; Naline, E.; Faisy, C.; Blouquit-Laye, S.; Couderc, L.; Le Guen, M.; Fischler, M.; Devillier, P. Intranasal drug delivery: an efficient and non-invasive route for systemic administration: focus on opioids. Pharmacol. Ther., 2012 , 134 (3), 366-379. -
  4. [16][16] Solans, C.; Izquierdo, P.; Nolla, J.; Azemar, N.; Garcia-Celma, M. J. Nano-emulsions. Curr. Opin. Colloid Interface Sci., 2005 , 10 (3-4), 102-110. -
  5. [30][30] Brooks, B.W.; Richmond, H. Dynamics of liquid-liquid inversion using non-ionic surfactants. Colloids Surf. , 1991 , 58 (1-2), 131-148. -
  6. [32][32] Becher, S.E.; Schick, M.J. Macroemulsions. In: Surfactant Science Series, Nonionic Surfactants - Physical Chemistry . Schick, M.J., Ed.; Marcel Dekker: New York: Marcel Dekker Inc. (Ed.), 1987 . Vol. 23, pp. 435-491.
  7. [33][33] Sajjadi, S.; Jahanzad, F.;, Brooks, B.W. Phase inversion in abnormal O/W/O emulsions: effect of surfactant - concentration. Ind. Eng. Chem. Res. , 2002 , 41 , 6033-6041. 567 -
  8. [34][34] Shinoda, K.; Friberg, S.E. Factors affecting the phase inversion temperature in an emulsion. In: Emulsions 568 2. and solubilization ; Shinoda, K.; Friberg, S.E., Eds.; Wiley-Interscience: New York, 1986 , pp. 96-123. 569 -
  9. [38][38] Salager, J.L.; Forgiarini, A.; Marquéz, L.; Peña, A.; Pizzino, A.; Rodriguez, M.P.; González, M.R. Using 577 emulsion inversion in industrial process. Adv. Colloid Interface Sci. , 2004 , 259 , 108-109. 578 579 580 -
  10. [40][40] Kunieda, H.; Fukui, Y.; Uchiyama, H.; Solans, C. Spontaneous formation of highly concentrated water-inoil emulsions (gel-emulsions). Langmuir , 1996 , 12 (9), 2136-2140. -
  11. [43][43] Thakur, N.; Garg, G.; Sharma, P. K.; Kumar, N. Nanoemulsions: a review on various pharmaceutical applications. Global J. Pharmacol., 2012 , 6 (3), 222-225. -
  12. [48][48] Patel, R. P.; Joshi, J. R. An overview on nanoemulsion: A novel approach. Int. J. Pharm. Sci. Res., 2012 , 3 (12), 4640-4650. -
  13. [59][59] Mahajan, H. S.; Dinger, S. B. Design and in vitro evaluation of nanoemulsion for nasal delivery of artemether. Indian J. Novel Drug Deliv., 2011 , 3 (4), 272-277. -
  14. [60][60] Hosny, K. M.; Banjar, Z. M. The formulation of a nasal nanoemulsion zaleplon in situ gel for the treatment of insomnia. Expert Opin. Drug Deliv., 2013 , 10 (8), 1033-1041. -
  15. [63][63] Gugulothu, D.; Pathak, S.; Suryavanshi, S.; Sharma, S.; Patravale, V. Self-microemulsifiyng suppository formulation of β-artemether. AAPS PharmSciTech, 2010 , 11 (3), 1179-1184. -
  16. [70][70] Bielinska, A. U.; Makidon, P. E.; Janczak, K. W.; Blanco, L. P.; Swanson, B.; Smith, D. M.; Pham, T.; 652 Szabo, Z.; Kukowska-Latallo, J. F.; Baker, J. R.,Jr Distinct pathways of humoral and cellular immunity 653 induced with the mucosal administration of a nanoemulsion adjuvant. J. Immunol., 2014 , 192 (6), 2722654 2733. 655 -
  17. [71][71] Davis, S. Nasal vaccines. Adv. Drug Deliv. Rev., 2001 , 51 (1), 21-42. 656 -
  18. [80][80] Hamouda, T.; Sutcliffe, J. A.; Ciotti, S.; Baker, J. R.,Jr Intranasal immunization of ferrets with commercial 678 trivalent influenza vaccines formulated in a nanoemulsion-based adjuvant. Clin. Vaccine Immunol., 2011 , 679 18 (7), 1167-1175. 680 -
  19. [96][96] Samia, O.; Hanan, R.; Kamal, E. T. Carbamazepine Mucoadhesive Nanoemulgel (MNEG) as brain targeting delivery system via the olfactory mucosa. Drug Deliv., 2012 , 19 (1), 58-67. -
  20. [102][102] Jain, N.; Akhter, S.; Jain, G.K.; Khan, Z.I.; Khar, R.K.; Ahmad, F.J. Antiepileptic intranasal amiloride loaded mocoadhesive nanoemulsion: development and safety assessment. J. Biomed. Nanotechnol. , 2011 , 7 , 142-143. -
  21. [103][103] Davis, K.L.; Powchick, P. Tacrine. Lancet, 1995 , 345 (8950), 625-630.

Cited by

See all 75

Metadata

Authors
Comfort, C., Garrastazu, G., Pozzoli, M., & Sonvico, F.
Affiliations
University of Technology Sydney (AU)
Venue
Current Topics in Medicinal Chemistry
Published
2015-02-10
Volume
15
Issue
4
Pages
356-368
ISSN
1568-0266 (ISSN-L)
OpenAlex
W2115015610
Cited by
69
References
81
Citations by year
2026: 2 · 2025: 6 · 2024: 8 · 2023: 7 · 2022: 9 · 2021: 11 · 2020: 6 · 2019: 11 · 2018: 5 · 2017: 2 · 2016: 2
FWCI
1.66
Type
journal article
Language
en
Open access
closed
Locations
  • Current Topics in Medicinal Chemistry (publishedVersion)
  • PubMed (publishedVersion)
  • UTS ePRESS (University of Technology Sydney) (submittedVersion)
Topics
  • Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmaceutical Science › Advanced Drug Delivery Systems
  • Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Inhalation and Respiratory Drug Delivery
  • Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmaceutical Science › Advancements in Transdermal Drug Delivery
Keywords
intranasal drug delivery, nanoemulsions, nose-to-brain delivery, mucosal adjuvant, nasal mucosa, bioavailability, first-pass metabolism, cilia
MeSH terms
Administration, Intranasal, Emulsions, Humans, Nasal Mucosa, Nanostructures

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Opportunities and Challenges for the Nasal Administration of Nanoemulsions. https://app.cochat.ai/papers/10.2174/1568026615666150108144655
The paper
Comfort, C., Garrastazu, G., Pozzoli, M., & Sonvico, F. (2015). Opportunities and Challenges for the Nasal Administration of Nanoemulsions. Current Topics in Medicinal Chemistry. https://doi.org/10.2174/1568026615666150108144655

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.